Drugs

Interpretation of Antibacterial Susceptibility Reports: In Vitro versus Clinical Break-Points
pp. 163-166(4)
Authors: Amsden G.W.; Duran J.M.

Role of Global Surveillance in Combating Bacterial Resistance
pp. 167-173(7)
Authors: Marchese A.; Schito G.C.

Comparative Review of Topical Ophthalmic Antibacterial Preparations
pp. 175-185(11)
Authors: Robert P-Y.; Adenis J-P.

Prophylaxis against Herpesvirus Infections in Transplant Recipients
pp. 187-196(10)
Author: Ljungman P.

Safety Profiles for the HMG-CoA Reductase Inhibitors: Treatment and Trust
pp. 197-206(10)
Author: Davidson M.H.

New Insights into the Second Generation Antihistamines
pp. 207-236(30)
Authors: Timmerman H.; Walsh G.M.; Annunziato L.; Frossard N.; Knol K.; Levander S.; Nicolas J-M.; Taglialatela M.; Tharp M.D.; Tillement J.P.

Treatment Options for Sleep Apnoea
pp. 237-251(15)
Authors: Grunstein R.R.; Hedner J.; Grote L.

Omalizumab
pp. 253-260(8)
Authors: Easthope S.; Jarvis B.

Omalizumab: A Viewpoint by Anthony J. Frew
pp. 261-261(1)
Author: Frew A.J.

Omalizumab: A Viewpoint by Pascal Demoly
pp. 261-261(1)
Author: Demoly P.

Oseltamivir: A Review of its Use in Influenza
pp. 263-283(21)
Authors: McClellan K.; Perry C.M.

Zafirlukast: An Update of its Pharmacology and Therapeutic Efficacy in Asthma
pp. 285-315(31)
Authors: Dunn C.J.; Goa K.L.